Literature DB >> 15557903

Total laparoscopic bypass for aortoiliac occlusive lesions: 93-case experience.

Marc Coggia1, Isabelle Javerliat, Isabelle Di Centa, Giovanni Colacchio, Jean Pascal Leschi, Michel Kitzis, Olivier A Goëau-Brissonnière.   

Abstract

OBJECTIVES: We describe our experience with a new technique of total laparoscopic bypass surgery to treat aortoiliac occlusive lesions.
MATERIAL AND METHODS: From November 2000 to December 2003, 93 total laparoscopic bypass procedures were performed to treat TASC (TransAtlantic Inter-Society Consensus document) grade C or D aortoiliac occlusive lesions. We also reimplanted 2 inferior mesenteric arteries, and performed 3 prosthesis-superior mesenteric bypasses and 2 suprarenal aorta endarterectomies. Our technique includes a sloping right lateral decubitus installation, which enables a simple transperitoneal left retrocolic or retrorenal approach to the infrarenal abdominal aorta. In patients with a hostile abdomen a retroperitoneal videoscopic approach was used. Aorta-prosthesis laparoscopic anastomoses are performed simply, which averts any trauma to the suture material.
RESULTS: Patients included 76 men and 17 women, with median patient age 61 years (range, 38-79 years). The approach to the aorta was always possible, in particular, in obese patients. It enabled stable aortic exposure during performance of the laparoscopic aorta-prosthesis anastomosis. Median operative time was 240 minutes (range, 150-450 minutes). Median aortic clamping time measured to unclamping of the first prosthetic limb was 67.5 minutes (range, 30-135 minutes). Median duration of aorta-prosthesis anastomosis was 30 minutes (range, 12-90 minutes). The longest durations were mainly observed during the learning curve. Thirty-day postoperative mortality was 4% (4 of 93 patients). Two patients died of myocardial infarction. One patient with American Society of Anesthesiologists grade 4 disease operated on to treat critical ischemia died of multiple organ system failure, and 1 patient died of colonic ischemia. Major nonlethal postoperative complications were observed in 4 patients, and included lung atelectasia in 2 patients, graft infection in 1 patient operated on emergently to treat aortic occlusion, and secondary spleen rupture at day 5 in 1 patient. Median hospital stay was 7 days (range, 2-57 days). With a mean follow-up of 19 months (range, 1-37 months), complete recovery was observed in 89 patients, and all grafts were patent. One patient had kinking of a prosthetic limb at the groin, and in 1 patient Staphylococcus epidermidis graft infection developed, which was treated with in situ replacement with a rifampin-bonded graft.
CONCLUSION: Total laparoscopic aortic bypass is feasible. In patients with TASC C and D aortoiliac occlusive lesions, short-term outcomes are comparable to those with conventional aortic bypass. After the initial learning curve, laparoscopic technique may reduce the operative trauma of aortic bypass.

Entities:  

Mesh:

Year:  2004        PMID: 15557903     DOI: 10.1016/j.jvs.2004.08.013

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  10 in total

1.  Real-time magnetic resonance imaging-guided endovascular recanalization of chronic total arterial occlusion in a swine model.

Authors:  Amish N Raval; Parag V Karmarkar; Michael A Guttman; Cengizhan Ozturk; Smita Sampath; Ranil DeSilva; Ronnier J Aviles; Minnan Xu; Victor J Wright; William H Schenke; Ozgur Kocaturk; Alexander J Dick; Venkatesh K Raman; Ergin Atalar; Elliot R McVeigh; Robert J Lederman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

2.  Retroperitoneal approach via paramedian incision for aortoiliac occlusive disease.

Authors:  Bilgin Emrecan; Gokhan Onem; Erkin Ocak; Murat Arslan; Baki Yagci; Ahmet Baltalarli; Beyza Akdag
Journal:  Tex Heart Inst J       Date:  2010

3.  Robot-assisted laparoscopic surgery of the infrarenal aorta : the early learning curve.

Authors:  J Diks; D Nio; V Jongkind; M A Cuesta; J A Rauwerda; W Wisselink
Journal:  Surg Endosc       Date:  2007-03-01       Impact factor: 4.584

4.  Early Experiences of Laparoscopic Aortofemoral Bypass in Korea-report from a Single Center.

Authors:  Taeseung Lee; Hyung-Ho Kim; Ho-Seong Han; Seung Kee Min; Jongwon Ha; Sang Joon Kim
Journal:  Ann Vasc Dis       Date:  2009-04-15

5.  A comparative cohort study of totally laparoscopic and open aortobifemoral bypass for the treatment of advanced atherosclerosis.

Authors:  Syed S H Kazmi; Jørgen Junkichi Jørgensen; Jon Otto Sundhagen; Anne Helene Krog; Tor L Flørenes; Dagfinn Kollerøs; Michael Abdelnoor
Journal:  Vasc Health Risk Manag       Date:  2015-09-18

6.  Patient-perceived health-related quality of life before and after laparoscopic aortobifemoral bypass.

Authors:  Syed Sh Kazmi; Anne H Krog; Simen T Berge; Jon O Sundhagen; Mehdi Sahba; Ragnhild S Falk
Journal:  Vasc Health Risk Manag       Date:  2017-05-12

Review 7.  Totally laparoscopic aortobifemoral bypass surgery in the treatment of aortoiliac occlusive disease or abdominal aortic aneurysms - a systematic review and critical appraisal of literature.

Authors:  Ingeborg Helgetveit; Anne H Krog
Journal:  Vasc Health Risk Manag       Date:  2017-05-18

8.  A Short Series of Laparoscopic Mesenteric Bypasses for Chronic Mesenteric Ischemia.

Authors:  Syed Sajid Hussain Kazmi; Simen Tveten Berge; Mehdi Sahba; Asle Wilhelm Medhus; Jon Otto Sundhagen
Journal:  Vasc Health Risk Manag       Date:  2020-03-20

9.  Quality of Life (QoL) Assessment in the Patients Operated with Either Laparoscopic or an Open Aortobifemoral Bypass for Aortoiliac Occlusive Disease (AIOD): 2 Years Results of a Randomized Controlled Trial.

Authors:  Mehdi Sahba; Anne Helene Krog; Erik Mulder Pettersen; Torbjørn Wisløff; Jon Otto Sundhagen; Syed Sajid Hussain Kazmi
Journal:  Vasc Health Risk Manag       Date:  2022-02-19

10.  Cost-utility analysis comparing laparoscopic vs open aortobifemoral bypass surgery.

Authors:  Anne Helene Krog; Mehdi Sahba; Erik M Pettersen; Torbjørn Wisløff; Jon O Sundhagen; Syed Sh Kazmi
Journal:  Vasc Health Risk Manag       Date:  2017-06-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.